Search Orphan Drug Designations and Approvals
-
Generic Name: | Allogeneic bone marrow-derived mesenchymal stromal cells (MSCs) |
---|---|
Date Designated: | 12/02/2021 |
Orphan Designation: | Treatment of Hypoplastic Left Heart Syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Longeveron, Inc. 1951 NW 7th Ave., Suite 520 Miami, Florida 33136 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-